Alzheimer’s Disease: Perspective on Therapeutic Options and Recent Hallmarks in Clinical Research
نویسندگان
چکیده
Alzheimer’s disease (AD) is a progressive neurodegenerative, primarily concerned and leading cause of mortality worldwide which has no cure so far, the world. The progresses from memory loss to cognitive decline gradually. severity grows up mild, moderate severe. Hallmarks research AD reported, are identification amyloid-beta (Aβ) plaques tau protein tangles between within neuronal cells, oxidative stress, low
منابع مشابه
Recent advances: personalised use of current Crohn’s disease therapeutic options
To cite: Vermeire S, Ferrante M, Rutgeerts P. Gut 2013;62:1511–1515. ABSTRACT Several aspects of the management of Crohn’s disease (CD) are shared between patients. The goal of all therapies should be to achieve clinical and endoscopic remission in a timely manner to avoid disease progression and abdominal resections. The way this goal is achieved may differ and predicting how the disease will ...
متن کاملParkinson’s Disease: Therapeutic Options
Parkinson’s disease is an idiopathic, relentlessly progressive, neurologic disorder manifested clinically by tremor, bradykinesia, rigidity, and postural instability. After completing the diagnostic procedure and having verified the need to start drug treatment, we follow the criteria for therapy aimed at maximum benefits with minimal side effects in the short and long term. This paper examines...
متن کاملPremature Menopause: Clinical Significance and therapeutic Options 61 PREMATURE MENOPAUSE: CLINICAL SIGNIFICANCE AND THERAPEUTIC OPTIONS
When we use the term “premature menopause” or climacterium praecox, we mean cessation of the normal cyclic ovarian function prior to the age of 40. Some authors have defined the limit at an even earlier age, namely 35 and in some cases even 30 [1]. Especially in young women, speaking of a prema ture menopause often causes problems for psychological reasons. The thought of being menopausal at s...
متن کاملO9: Mechanisms and Therapeutic Options in Multiple Sclerosis
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. Clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. At the moment MS is incurable, thus there is an unmet need for therapeutic options.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of pharmaceutical research and allied sciences
سال: 2021
ISSN: ['2277-3657']
DOI: https://doi.org/10.51847/vic6sagcyq